Frequency and resistance of CD95 (Fas/Ap
โ
Motomu Shimizu; Takayuki Yoshimoto; Mayumi Sato; Akio Matsuzawa; Yasutaka Takeda
๐
Article
๐
2006
๐
John Wiley and Sons
๐
French
โ 598 KB
## Abstract It is important for more effective gene therapies to clarify the mechanisms by which cDNA integrated into cells can maintain or lose its function __in vivo__. We evaluated genetic and epigenetic events leading to alternation of the introduced CD95 (Fas/Apoโ1) gene as a model of gene the